HealthyWay Inc. disclosed that it bought back 51,000 ordinary shares on 17 April 2026 through on-market transactions on the Hong Kong Stock Exchange. The repurchase price ranged between HKD 4.64 and HKD 4.65 per share, resulting in a total cash outlay of HKD 0.24 million.

Prior to the transaction, HealthyWay had 874.65 million issued shares (excluding treasury shares) and 3.06 million shares held in treasury, making a total issued share capital of 877.70 million shares. Following the buyback, the number of issued shares outstanding fell by 0.006 % to 874.59 million, while treasury shares increased to 3.11 million. The overall issued share capital remained unchanged at 877.70 million shares because the repurchased shares are being held in treasury rather than cancelled.

The buyback forms part of a repurchase mandate approved on 3 June 2025, which authorises the company to repurchase up to 87.77 million shares. Including the latest transaction, HealthyWay has repurchased a cumulative 3.11 million shares under this mandate, equivalent to 0.35 % of the company’s issued share count on the mandate date.

Under Hong Kong Stock Exchange rules, HealthyWay is subject to a moratorium on new share issues or treasury-share sales until 16 May 2026, 30 days after the latest repurchase.